Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

3?-Chloro-N-methoxy-N-methyl-cholest-5-ene-24-carboxamide.

ABSTRACT: The title compound, C26H42ClNO2, is a 3?-chloro steroid with a Weinreb amide at the C-24 position. The two cyclo-hexane and the cyclo-hexene rings adopt chair and boat conformations, respectively. The cyclo-pentane ring has an envelope conformation.

SUBMITTER: Gonzalez K

PROVIDER: S-EPMC3589044 | biostudies-literature | 2012 Dec

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Publications

3β-Chloro-N-methoxy-N-methyl-cholest-5-ene-24-carboxamide.

González Karilys K Nieves Karinel K Rodríguez Abimael D AD

Acta crystallographica. Section E, Structure reports online 20121128 Pt 12

The title compound, C26H42ClNO2, is a 3β-chloro steroid with a Weinreb amide at the C-24 position. The two cyclo-hexane and the cyclo-hexene rings adopt chair and boat conformations, respectively. The cyclo-pentane ring has an envelope conformation. ...[more]

PMID: 23476280

Similar Datasets

3-Methyl-5α-cholest-2-ene.

Project description:In the title cholestane derivative, C(28)H(48) [systematic name: (1S,2S,7R,10R,11R,14R,15R)-2,5,10,15-tetra-methyl-14-[(2R)-6-methyl-heptan-2-yl]tetra-cyclo-[8.7.0.0(2,7).0(11,15)]hepta-dec-4-ene], the cyclo-hexene ring adopts a half-chair conformation. The parent 5α-cholest-2-ene and the equivalent fragment of the title compound are almost superimposable (r.m.s. deviation = 0.033 Å).

| S-EPMC3008105 | biostudies-literature

A second monoclinic polymorph of 3?-chloro-cholest-5-ene.

Project description:The title compound, C(27)H(45)Cl, is a second monoclinic polymorph which crystallizes in the space group P2(1) with four crystallographically independent mol-ecules in the asymmetric unit. The structure was previously reported [Bernal et al. (1940 ?). Philos. Trans. R. Soc. London Ser. B, 239, 135-182; Vani & Vijayan (1979 ?). Mol. Cryst. Liq. Cryst.51, 253-264], also in the space group P2(1), but with two unique mol-ecules in the asymmetric unit. As in the previously reported structures, rings A and C in the mol-ecule adopt chair conformations with half-chair conformations for rings B and D. The ring junctions B-C and C-D are trans, whereas the junction A-B is quasi-trans. In the crystal structure, mol-ecules are arranged in a head-to-tail fashion along a and are stacked along the b axis.

| S-EPMC2979588 | biostudies-literature

Cholest-5-ene.

Project description:The asymmetric unit of the title compound, C(27)H(46), contains two crytallographically independent cholest-5-ene mol-ecules (A and B). In each mol-ecule, the three six-membered rings are all in chair conformations, while the five-membered ring is in a twist conformation. The terminal isopropyl group of mol-ecule A has a (-)-gauche conformation, whereas that of mol-ecule B has a (+)-gauche conformation. No significant inter-molecular inter-actions are observed in the crystal structure.

| S-EPMC3120455 | biostudies-literature

(Z)-6-[(5-Chloro-2-hydroxy-anilino)-methyl-ene]-4-methoxy-cyclo-hexa-2,4-dienone 0.25-hydrate.

Project description:The title compound, C(14)H(12)ClNO(3)·0.25H(2)O, exists in the keto-amine form, and the aromatic rings are oriented at a dihedral angle of 7.24 (7)°. Bifurcated intra-molecular N-H⋯(O,O) hydrogen bonds result in the formation of planar six- and five-membered rings. In the crystal structure, inter-molecular O-H⋯O and C-H⋯O hydrogen bonds link the mol-ecules into chains. π-π contacts between benzene rings [centroid-centroid distance = 3.5065 (9) Å] may further stabilize the structure. There also exists a weak C-H⋯π inter-action.

| S-EPMC2977782 | biostudies-literature

2-Chloro-3-hydroxy-methyl-6-methoxy-quinoline.

Project description:All the non-H atoms of the title compound, C(11)H(10)ClNO(2), are roughly coplanar (r.m.s. deviation = 0.058?Å). In the crystal, adjacent mol-ecules are linked by an O-H?N hydrogen bond, generating chains running along the a axis.

| S-EPMC2980227 | biostudies-literature

Methyl 4-(3-chloro-prop-oxy)-3-methoxy-benzoate.

Project description:In the title compound, C(12)H(15)ClO(4), the molecules are linked by C-H?O interactions.

| S-EPMC2968407 | biostudies-literature

N-(4-Chloro-phen-yl)-4-methyl-piperidine-1-carboxamide.

Project description:In the title compound, C(13)H(17)ClN(2)O, the piperidine ring adopts a chair conformation and the N atom in that ring is close to pyramidal (bond angle sum = 357.5°). In the crystal, mol-ecules are linked into C(4) chains propagating in [010] by N-H?O hydrogen bonds.

| S-EPMC3152019 | biostudies-literature

(E)-1-[(2-Chloro-5-methyl-pyridin-3-yl)methyl-ene]thiosemicarbazide.

Project description:The title compound, C(8)H(9)ClN(4)S, which has potential insecticidal activity, was synthesized by the reaction of 2-chloro-5-methyl-nicotinaldehyde and thio-semicarbazide. In the crystal structure, the mol-ecules are linked via inter-molecular N-H⋯N, N-H⋯S and N-H⋯Cl hydrogen bonds, forming a three-dimensional network stacked down a.

| S-EPMC2983548 | biostudies-literature

(E)-4-Chloro-N-[(5-chloro-3-methyl-1-phenyl-1H-pyrazol-4-yl)methyl-ene]aniline.

Project description:In the title compound, C(17)H(13)Cl(2)N(3), the dihedral angle between the pyrazole ring system and 4-chloro-phenyl ring is 26.1?(2)°. The C=N bond linking the two aromatic rings has an E conformation.

| S-EPMC2970186 | biostudies-literature

3?-Chloro-cholest-5-en-7-one.

Project description:The title compound, C(27)H(43)ClO, is a steroid derivative composed of a saturated carbon fused-ring framework with an alkyl side chain. The A and C rings have chair conformations and the B and D rings assume half-chair conformations. The cholesterol side chain is fully extended with a gauche, trans conformation of the terminal methyl groups. In the crystal structure, the molecules are aligned in an antiparallel fashion, forming alternate layers. These layers are then linked via C-H?O hydrogen bonds, forming a three-dimensional network.

| S-EPMC2983643 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data